• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Ian D. Davis, Wanling Xie, Carmel Pezaro, et al. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category. Eur Urol 2017;71:970-8: The Change in Baseline IMDC Prognostic Category: From the Past, Implications for the Future.

作者信息

Iacovelli Roberto, Artibani Walter, Tortora Giampaolo

机构信息

Medical Oncology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Urology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

出版信息

Eur Urol. 2017 Jun;71(6):e175-e176. doi: 10.1016/j.eururo.2016.12.012. Epub 2016 Dec 30.

DOI:10.1016/j.eururo.2016.12.012
PMID:28043706
Abstract
摘要

相似文献

1
Re: Ian D. Davis, Wanling Xie, Carmel Pezaro, et al. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category. Eur Urol 2017;71:970-8: The Change in Baseline IMDC Prognostic Category: From the Past, Implications for the Future.回复：伊恩·D·戴维斯、谢婉玲、卡梅尔·佩扎罗等。根据国际转移性肾细胞癌数据库联盟预后分类的基线变化评估二线靶向治疗对肾细胞癌的疗效。《欧洲泌尿外科杂志》2017年；71卷：970 - 978页：基线国际转移性肾细胞癌数据库联盟预后分类的变化：从过去到未来的启示
Eur Urol. 2017 Jun;71(6):e175-e176. doi: 10.1016/j.eururo.2016.12.012. Epub 2016 Dec 30.
2
Reply to Roberto Iacovelli, Walter Artibani, and Giampaolo Tortora's Letter to the Editor re: Ian D. Davis, Wanling Xie, Carmel Pezaro, et al. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category. Eur Urol 2017;71:970-8.致罗伯托·亚科韦利、沃尔特·阿尔蒂巴尼和詹保罗·托尔托拉给编辑的信的回复，主题为：伊恩·D·戴维斯、谢婉玲、卡梅尔·佩扎罗等人。根据国际转移性肾细胞癌数据库联盟预后分类中与基线的变化评估二线靶向治疗对肾细胞癌的疗效。《欧洲泌尿外科杂志》2017年；71卷：970 - 978页
Eur Urol. 2017 Jun;71(6):e177-e178. doi: 10.1016/j.eururo.2016.12.013. Epub 2016 Dec 29.
3
Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.分子亚型提高国际转移性肾细胞癌数据库联盟预后模型的预后价值。
Oncologist. 2017 Mar;22(3):286-292. doi: 10.1634/theoncologist.2016-0078. Epub 2017 Feb 20.
4
Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category.根据国际转移性肾细胞癌数据库联盟预后分类中基线变化，二线靶向治疗肾细胞癌的疗效。
Eur Urol. 2017 Jun;71(6):970-978. doi: 10.1016/j.eururo.2016.09.047. Epub 2016 Oct 19.
5
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study.国际转移性肾细胞癌数据库联盟模型作为一线靶向治疗后转移性肾细胞癌患者的预后工具：一项基于人群的研究。
Lancet Oncol. 2015 Mar;16(3):293-300. doi: 10.1016/S1470-2045(14)71222-7. Epub 2015 Feb 12.
6
Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings.国际转移性肾细胞癌数据库协作组（IMDC）模型重新分类对一线和二线接受靶向治疗的转移性肾细胞癌患者的影响。
Urol Oncol. 2016 Jul;34(7):293.e17-25. doi: 10.1016/j.urolonc.2016.02.023. Epub 2016 Apr 1.
7
Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk model.中性粒细胞与淋巴细胞比值在接受一线及后续二线靶向治疗的转移性肾细胞癌患者中的预后价值：改良IMDC风险模型的提议
Urol Oncol. 2017 Feb;35(2):39.e19-39.e28. doi: 10.1016/j.urolonc.2016.10.001. Epub 2016 Nov 4.
8
Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.细胞减灭性肾切除术治疗肾细胞癌同步转移患者：来自国际转移性肾细胞癌数据库联盟的结果。
Eur Urol. 2014 Oct;66(4):704-10. doi: 10.1016/j.eururo.2014.05.034. Epub 2014 Jun 13.
9
Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116.回复：马修·S·恩斯特、维沙尔·纳瓦尼、J·康纳·韦尔斯等人。国际转移性肾细胞癌数据库联盟预后分组在当代转移性肾细胞癌一线联合治疗中的结果。《欧洲泌尿外科杂志》。2023年；84卷：109 - 116页。
Eur Urol. 2023 Jul;84(1):e16-e17. doi: 10.1016/j.eururo.2023.02.030. Epub 2023 Apr 13.
10
Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116.回复：马修·S·恩斯特、维沙尔·纳瓦尼、J·康纳·韦尔斯等人。国际转移性肾细胞癌数据库联盟预后分组在当代转移性肾细胞癌一线联合治疗中的结果。《欧洲泌尿外科杂志》。2023年；84卷：109 - 116页。
Eur Urol. 2023 Oct;84(4):e96-e97. doi: 10.1016/j.eururo.2023.05.041. Epub 2023 Jun 28.